Dexketoprofen and Ibuprofen in Long Bone Fractures

Ankara City Hospital

Status and phase: Enrolling; Phase 4

Conditions: Bone Fracture; Pain

Treatments: Drug: Dexketoprofen; Drug: Ibuprofen 800 mg

Study type: Interventional

Funder types: Other

Identifiers

NCT06060236

E2-23-4743

Details and patient eligibility

About

The aim of this study was to compare the efficacy of ibuprofen and dexketoprofen, two common analgesic drugs used in pain control in patients with long bone fractures.

Full description

Long bone fractures are the fractures of long bones (tibia, femur, humerus) in the human body. Such fractures usually occur as a result of trauma and are manifested by symptoms such as pain, swelling, bruising and limitation of movement. Effective control of pain can help the patient relax and facilitate the healing process. Ibuprofen and dexketoprofen, which belong to the class of non-steroidal anti-inflammatory drugs (NSAID), are among the analgesics commonly used in the pain management of all fractures. These drugs are thought to be able to relieve pain, reduce inflammation, and help patients move. However, each patient's individual response and tolerance may differ, so the efficacy and side effects of each drug may vary from patient to patient. This makes it difficult to determine which analgesic is more effective and safe in clinical practice. The fact that it is a subject that has not been done much in the literature has led us to do this study.

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• over 18 years
• Patients under 80 years of age
• Patients who agreed to participate in the study
• One of the tibia, femur and humerus bones is broken
• Patients with a VAS score of 50 and above
• Patients with no other injuries requiring emergency surgery
• Previously known adverse reactions to the active ingredient of the drugs to be used patients with no history
• Conscious patients
• Oriented cooperative patients

Exclusion criteria

• Patients under the age of 18 and over the age of 80
• Patients who did not agree to participate in the study
• Patients with vital signs outside the normal limits
• Patients with a history of adverse reactions to known NSAIDs
• Those who cannot determine the severity of pain on the VAS
• Patients with a VAS Score of 50 mm or less
• Those with other orthopedic injuries pregnant women
• Those with advanced systemic disease
• Those with malignancy
• Those with chronic liver and kidney disease
• Those who use neuro-psychiatric drugs with sedative and analgesic effects
• Those with a history of psychological and neurological diseases
• Patients using analgesics 8 hours before the examination

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

100 participants in 2 patient groups

ibuprofen

Experimental group

Description:

ibuprofen intravenous 800 mg

Treatment:

Drug: Ibuprofen 800 mg

dexketoprofen

Experimental group

Description:

dexketoprofen intravenous 50 mg

Treatment:

Drug: Dexketoprofen